XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

Note 12 – Stock-Based Compensation

 

A summary of the Company’s Share Incentive Plans are as follows:

 

2007 Share Incentive Plan

 

On December 12, 2007, shareholders approved the Company’s 2007 Share Incentive Plan (“2017 Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2017 Incentive Plan through December 12, 2017. The Plan expired in December 2017. As of December 31, 2023, there were 120,000 options outstanding under this plan.

 

2016 Share Incentive Plan

 

On December 9, 2016, shareholders approved the Company’s 2016 Share Incentive Plan (“2016 Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2016 Incentive Plan through December 9, 2026. As of December 31, 2023, there were 442,125 options outstanding under this plan.

 

2022 Share Incentive Plan

 

On July 14, 2022, shareholders approved the Company’s 2022 Share Incentive Plan (“2022 Incentive Plan”), in connection therewith, 515,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2022 Incentive Plan through July 14, 2032. As of December 31, 2023, there were 284,750 options outstanding under this plan.

 

Under the 2016 and 2022 Share Incentive Plans, the purchase price of the common stock under each option plan shall be determined by the Committee, provided, however, that such purchase price shall not be less than the fair market value of the shares on the date such option is granted. The stock options generally expire seven to ten years after the date of grant.

 

As of December 31, 2023, there were 26,948 shares available for grant under the 2016 Equity Incentive Plan and 188,930 shares available for grant under the 2022 Equity Incentive Plan.

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

 

Note 12 – Stock-Based Compensation (continued)

 

The Company recorded stock-based compensation of $0.9 million and $0.4 million for the years ended December 31, 2023 and 2022, respectively, that were included in the following line items in our Consolidated Statements of Operations (in thousands):

 

   2023   2022 
         
Cost of revenue  $120   $34 
Research and development   159    57 
Selling   94    27 
General and administrative   535    317 
           
Total stock-based compensation expense  $908   $435 

 

Stock-based compensation expense in both years included approximately $0.2 million related to restricted stock awards pursuant to a Director Compensation plan discussed below. The Company recognizes forfeitures of stock awards as they occur.

 

For the year ended December 31, 2023, the Company granted 254,000 stock options, vesting 25% per year over four years, with a ten-year life. The Company determined the fair value of stock options granted during the year ended December 31, 2023 is based upon weighted average assumptions as provided below.

 

Stock price  $14.02 
Exercise price  $14.02 
Dividend yield   0%
Expected volatility   72%
Risk-free interest rate   3.39%
Expected life (in years)   6.00 

 

The expected life is the number of years the Company estimates that the awards will be outstanding based on the simplified method that considers the vesting period and contractual period of the option. The Company has 846,875 of outstanding stock options under the three plans at December 31, 2023.

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

 

Note 12 – Stock-Based Compensation (continued)

 

The following table summarizes stock options awards for the years ended December 31, 2023 and 2022:

 

   Awards
(in Shares)
  

Weighted
Average

Exercise Price

 
Outstanding at December 31, 2021   618,500   $11.26 
           
Granted   198,500    5.04 
Expired / cancelled   (144,000)   11.72 
Exercised   -    - 
Outstanding at December 31, 2022   673,000    5.70 
Granted   254,000    14.02 
Expired / cancelled   (44,500)   6.57 
Exercised   (35,625)   4.53 
Outstanding at December 31, 2023   846,875    8.20 

 

The following table summarizes information about the outstanding and exercisable options at December 31, 2023:

 

   Options Outstanding   Options Exercisable 
       Weighted   Weighted           Weighted     
       Average   Average           Average     
Exercise  Number   Remaining   Exercise   Intrinsic   Number   Exercise   Intrinsic 
Price Range  Outstanding   Contractual   Price   Value   Exercisable   Price   Value 
$ 4.00-7.00   463,375    7.9   $4.55   $76,655    195,375   $4.47   $37,064 
$ 7.01-10.00   20,000    4.3   $8.07   $-    20,000   $8.07   $- 
$ 10.01-13.00   130,000    4.0   $11.51   $-    120,000   $10.52   $- 
$ 13.01-16.00   233,500    9.2   $14.11   $-    -   $-   $- 

 

As of December 31, 2023, there was $2.4 million of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 2.6 years.

 

Restricted Stock Awards

 

Pursuant to the Director Compensation plan approved on October 11, 2021, each of the five independent directors is entitled to compensation for an annual equity retainer in the amount of $40,000 per director, to be automatically granted on the date of the Company’s annual meeting of shareholders.

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

 

Note 12 – Stock-Based Compensation (continued)

 

The following table summarizes restricted stock awards for the years ended December 31, 2023 and 2022:

 

       Weighted 
       Average Grant 
   Shares of   Date Fair 
   Restricted Stock   Value 
Unvested outstanding at January 1, 2022   -   $- 
Granted   32,000    5.02 
Vested   (32,000)   5.02 
Forfeited or cancelled   -    - 
Unvested outstanding at December 31, 2022   -    - 
           
Granted   41,320    6.65 
Vested   (24,187)   6.81 
Forfeited or cancelled   -    - 
Unvested outstanding at December 31, 2023   17,133   $6.53 

 

The fair value of the restricted stock awards is recorded as stock-based compensation expense over the one-year vesting period and totaled $0.17 million $0.16 million for the years ending December 31, 2023 and 2022, respectively.

 

Restricted Stock Units

 

In prior years, the Company issued restricted stock units or RSUs. During the year ended December 31, 2022, 5,500 RSUs vested which had an intrinsic value of $22,745. No restricted stock units vested during the year ended December 31, 2023 and there were no RSUs outstanding as of December 31, 2023 and 2022.